Comparative effectiveness and safety of sarilumab vs Janus kinase inhibitors in late- and younger-onset rheumatoid arthritis.
Glucocorticoid (GC)- and methotrexate (MTX)-sparing strategies are clinically important in rheumatoid arthritis (RA), yet comparative real-world evidence for sarilumab (SAR) vs Janus kinase inhibitors (JAKi) is limited. Whether treatment effects differ by age at onset-late-onset…